Abstract Purpose Direct oral anticoagulants (DOACs) have been approved, for over a
decade, by both European and American medicine agencies, for treatment and prevention …

Purpose The objective of present study was to compare the safety and efficacy of resuming
direct-acting oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) in patients with …

Background The benefit of apixaban to reduce stroke risk in morbidly obese patients with
nonvalvular atrial fibrillation (AF) is still undetermined. The International Society of …

Atrial fibrillation (AF) is the most common cardiac arrhythmia. AF increases the risk of stroke,
heart failure, dementia, and hospitalization. Obesity significantly increases AF risk, both …

Our study aims to compare the utility of single antiplatelet therapy (SAPT) with dual
antiplatelet therapy (DAPT) following Left atrial appendage occlusion in patients whose post …

Phase III clinical trials for individual direct oral anticoagulants (DOACs) contained a limited
representation of subjects with abnormal body weight, which were mostly limited to a BMI> …

Background Atrial fibrillation (AF) is an irregular heart rhythm which is becoming more and
more common in this new era. Obesity is a risk factor for cardiovascular events, and obese …

Purpose Factor Xa Inhibitors have emerged as a first-line agent in the management of non-
valvular atrial fibrillation (NVAF), but there is a need for additional data surrounding their use …

Abstract Background and Aim Obesity affects nearly 650 million adults worldwide, and the
prevalence is steadily rising. This condition has significant adverse effects on cardiovascular …

Atrial fibrillation (AF) is a cardiac condition characterized by an irregular heart rhythm, which
is increasingly prevalent in the modern era. All international guidelines strongly advise the …